CLTS — Earth Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.10m
- $0.15m
2017 December 31st | 2018 December 31st | 2019 December 31st | C2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | — | — | — | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -6.79 | -0.438 | -0.054 | -1.82 | -1.58 |
Depreciation | |||||
Non-Cash Items | 6.75 | 0.399 | — | 1.79 | 1.54 |
Other Non-Cash Items | |||||
Changes in Working Capital | 0.038 | 0.038 | 0.053 | 0.01 | 0.026 |
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | 0 | 0 | 0 | -0.025 | -0.016 |
Other Investing Cash Flow Items | 0 | 0 | 0 | 0 | 0 |
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0 | 0 | 0 | 0 | 0 |
Financing Cash Flow Items | 0 | 0.062 | 0 | 0.025 | 0.016 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Cash from Financing Activities | 0 | 0 | 0 | 0.025 | 0.016 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0 | 0 | 0 | 0 | 0 |